Problems with stopping rules in the trials of risky therapies: the case of warfarin to prevent stroke in atrial fibrillation.
Problems with stopping rules in the trials of risky therapies: the case of warfarin to prevent stroke in atrial fibrillation. Clin Res. 1993 Oct; 41(3):482-6.